Share on Twitter Print Share by Email Share Back to top In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither...more
8/8/2025
/ Compliance ,
Drug Compounding ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
New Guidance ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Requirements ,
State and Local Government
On January 8, 2025, Governor Maura Healey signed into law H.B. 5159, “an Act enhancing the market review process.” This new law promises sweeping reform to reshape how health care businesses operate and grow...more
1/15/2025
/ Compliance ,
False Claims Act (FCA) ,
Health Care Providers ,
Healthcare Reform ,
Licensing Rules ,
Mergers ,
New Legislation ,
Private Equity ,
Regulatory Oversight ,
Regulatory Requirements ,
REIT ,
Reporting Requirements ,
State and Local Government